Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-07
DOI
10.1111/bcp.13731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparing granulocyte colony–stimulating factor filgrastim and pegfilgrastim to its biosimilars in terms of efficacy and safety: A meta-analysis of randomised clinical trials in breast cancer patients
- (2018) Edoardo Botteri et al. EUROPEAN JOURNAL OF CANCER
- Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III trials
- (2017) Nadia Harbeck et al. Future Oncology
- Impact of Fasting on Complete Blood Count Assayed in Capillary Blood Samples
- (2017) Barbara K Kościelniak et al. Labmedicine
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
- (2017) Matti Aapro et al. SUPPORTIVE CARE IN CANCER
- Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
- (2017) A. Krendyukov et al. SUPPORTIVE CARE IN CANCER
- Impact of Fasting on Complete Blood Count Assayed in Capillary Blood Samples
- (2017) Barbara K Kościelniak et al. LABORATORY MEDICINE
- Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer
- (2016) Nadia Harbeck et al. Future Oncology
- A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial
- (2016) Kimberly Blackwell et al. ONCOLOGIST
- Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe
- (2015) Bing-Bing Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Thomas J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
- (2015) Derek Weycker et al. SUPPORTIVE CARE IN CANCER
- The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
- (2015) Li Wang et al. SUPPORTIVE CARE IN CANCER
- Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
- (2014) Alena M. Pfeil et al. SUPPORTIVE CARE IN CANCER
- Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy
- (2013) Igor Bondarenko et al. BMC CANCER
- Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
- (2011) Bing-Bing Yang et al. CLINICAL PHARMACOKINETICS
- Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial
- (2010) Cornelius F. Waller et al. ANNALS OF HEMATOLOGY
- Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial
- (2010) Cornelius F. Waller et al. ANNALS OF HEMATOLOGY
- Development of a new G-CSF product based on biosimilarity assessment
- (2009) P. Gascon et al. ANNALS OF ONCOLOGY
- A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial
- (2008) Jorge Sierra et al. BMC CANCER
- Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function
- (2008) Bing-Bing Yang et al. JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started